Peritoneal resident macrophages in tumor metastasis and immunotherapy

被引:7
|
作者
Zhang, Yu [1 ]
Ouyang, Dongyun [2 ]
Chen, Youhai H. [1 ]
Xia, Houjun [1 ]
机构
[1] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Ctr Canc Immunol, Shenzhen, Peoples R China
[2] Jinan Univ, Coll Life Sci & Technol, Dept Immunobiol, Guangzhou, Peoples R China
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2022年 / 10卷
基金
中国国家自然科学基金;
关键词
resident macrophage; peritoneal metastasis; tumor immunity; immunotherapy; ontogeny; immune evasion; tumor microenvironment; tumor associated macrophage; EPITHELIAL OVARIAN-CANCER; OMENTAL MILKY SPOTS; T-CELLS; FUNCTIONAL POLARIZATION; TISSUE MACROPHAGES; SIGNALING AXIS; EXPRESSION; MONOCYTES; ORIGIN; MICROENVIRONMENT;
D O I
10.3389/fcell.2022.948952
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Macrophages residing in various tissues play crucial roles in innate immunity, tissue repair, and immune homeostasis. The development and differentiation of macrophages in non-lymphoid tissues are highly regulated by the tissue microenvironment. Peritoneum provides a unique metastatic niche for certain types of tumor cells. As the dominant immune cell type in peritoneal cavity, macrophages control the immune response to tumor and influence the efficacy of anti-tumor therapy. Considering the heterogeneity of macrophages in origin, metabolism, and function, it is always challenging to define the precise roles of macrophages in tumor microenvironment. We review here recent progresses in peritoneal resident macrophage research in the context of physiological and metastatic tumor conditions, which may benefit the development of new anti-tumor therapies through targeting macrophages.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Mouse Tissue-Resident Peritoneal Macrophages in Homeostasis, Repair, Infection, and Tumor Metastasis
    Ardavin, Carlos
    Alvarez-Ladron, Natalia
    Ferriz, Margarita
    Gutierrez-Gonzalez, Alejandra
    Vega-Perez, Adrian
    ADVANCED SCIENCE, 2023, 10 (11)
  • [2] Intraperitoneal metastasis of ovarian cancer: new insights on resident macrophages in the peritoneal cavity
    Miyamoto, Taito
    Murphy, Brennah
    Zhang, Nan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] Gata6+ resident peritoneal macrophages promote the growth of liver metastasis
    Hossain, Mokarram
    Shim, Raymond
    Lee, Woo-Yong
    Sharpe, Arlene H.
    Kubes, Paul
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [4] Gata6+ resident peritoneal macrophages promote the growth of liver metastasis
    Mokarram Hossain
    Raymond Shim
    Woo-Yong Lee
    Arlene H. Sharpe
    Paul Kubes
    Nature Communications, 13
  • [5] IMMUNOTHERAPY OF MURINE SARCOMA BY ADOPTIVE TRANSFER OF RESIDENT PERITONEAL-MACROPHAGES PROLIFERATING IN CULTURE
    BARTHOLEYNS, J
    LOMBARD, Y
    POINDRON, P
    ANTICANCER RESEARCH, 1988, 8 (01) : 145 - 151
  • [6] Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer
    Che, Keying
    Luo, Yuting
    Song, Xueru
    Yang, Zhe
    Wang, Hanbing
    Shi, Tao
    Wang, Yue
    Wang, Xuan
    Wu, Hongyan
    Yu, Lixia
    Liu, Baorui
    Wei, Jia
    EMBO MOLECULAR MEDICINE, 2024, 16 (02) : 251 - 266
  • [7] ON THE ORIGIN OF PERITONEAL RESIDENT MACROPHAGES .3. EM-IMMUNOCYTOCHEMICAL STUDIES ON THE ORIGIN OF MOUSE PERITONEAL RESIDENT MACROPHAGES
    DEBAKKER, JM
    DEWIT, AW
    KOERTEN, HK
    GINSEL, LA
    DAEMS, WT
    JOURNAL OF SUBMICROSCOPIC CYTOLOGY AND PATHOLOGY, 1985, 17 (02) : 153 - 159
  • [8] CONCANAVALIN-A IS MITOGENIC FOR RESIDENT PERITONEAL MACROPHAGES
    WANG, AL
    FEDERATION PROCEEDINGS, 1979, 38 (03) : 1418 - 1418
  • [9] INVIVO LABELING OF RESIDENT PERITONEAL-MACROPHAGES
    MELNICOFF, MJ
    MORAHAN, PS
    JENSEN, BD
    BRESLIN, EW
    HORAN, PK
    JOURNAL OF LEUKOCYTE BIOLOGY, 1988, 43 (05) : 387 - 397
  • [10] Small peritoneal macrophages are accelerators of peritoneal metastasis of colorectal cancer
    Yang, Wanli
    Jiang, Feng
    Xu, Lixia
    Pang, Nan
    Yang, Chao
    Yu, Ruihua
    Chen, Haiqun
    TRANSLATIONAL CANCER RESEARCH, 2025,